M. Lehmann (München, Germany), C. Britto (New Haven, United States of America)
Predictors for significant changes in serum sulfated glycosaminoglycans at COPD exacerbations
E. Papakonstantinou (Basel/Thessaloniki, Switzerland), F. Baty (St. Gallen, Switzerland), M. Roth (Basel, Switzerland), M. Tamm (Basel, Switzerland), D. Stolz (Basel, Switzerland)
|  |
Downregulation of lysosome-associated membrane protein-2A accelerates cigarette smoke extract-induced aging and apoptosis in human bronchial epithelial cells
K. Lee (Seoul, Republic of Korea), Y. Jeong (Goyang-si, Republic of Korea), J. Kim (Seoul, Republic of Korea), C. Lee (Seoul, Republic of Korea), C. Yoo (Seoul, Republic of Korea)
| |
A-kinase anchoring proteins diminish lung EMT induced by TGF-ß1/cigarette smoke
M. Schmidt (Groningen, Netherlands), H. Zuo (Groningen, Netherlands), V. Nikolaev (Hamburg, Germany), M. Van Der Veen (Groningen, Netherlands)
| |
INFLUENCE OF INDUCED IMMUNOSUPRESSION ON INFLAMMATION AND LUNGS REMODELING ON THE COPD MODEL
O. Titova (Saint-Petersburg, Russian Federation), N. Kuzubova (Saint-Petersburg, Russian Federation), E. Lebedeva (Saint-Petersburg, Russian Federation), T. Preobrajenskaya (Saint-Petersburg, Russian Federation), E. Volchkova (Saint-Petersburg, Russian Federation)
|  |
Beneficial effects of HDAC6 inhibition on airway epithelial barrier function
M. Collins (Gothenburg, Sweden), J. Horndahl (Gothenburg, Sweden), R. Svärd (Gothenburg, Sweden), T. Andreasson (Gothenburg, Sweden), A. Cavallin (Gothenburg, Sweden), U. Gehrmann (Gothenburg, Sweden), A. Åstrand (Gothenburg, Sweden)
| |
Mesenchymal stem cell therapy in a model of chronic inflammatory lung disease
D. Doherty (Belfast, United Kingdom), L. Roets (Belfast, United Kingdom), R. Delaney (Belfast, United Kingdom), A. Krasnodembskaya (Belfast, United Kingdom), M. Mall (Berlin, Germany), C. Taggart (Belfast, United Kingdom), S. Weldon (Belfast, United Kingdom)
| |
Inhibition of uPA-uPAR signaling restores respiratory epithelial barrier function in asthma and COPD
M. Webster (Biberach an der Riss, Germany), V. Schroeder (Biberach an der Riss, Germany), E. Peter (Biberach an der Riss, Germany), I. Kollak (Biberach an der Riss, Germany), J. Schuett (Biberach an der Riss, Germany), B. Guilliard (Biberach an der Riss, Germany), I. Christ (Biberach an der Riss, Germany), D. Lamb (Biberach an der Riss, Germany), N. Goeghagen (Ridgefield, United States of America), T. Hall (Ridgefield, United States of America), J. Li (Ridgefield, United States of America), M. Thomas (Biberach an der Riss, Germany), F. Buettner (Biberach an der Riss, Germany), F. Schiele (Biberach an der Riss, Germany), G. Schnapp (Biberach an der Riss, Germany), M. Hoffmann (Biberach an der Riss, Germany), J. Garnett (Biberach an der Riss, Germany)
| |
Disease-specific inflammatory environments induce different anti-inflammatory MSC actions that play critical roles in mitigating lung injury
S. Rolandsson Enes (Burlington, United States of America), S. C. Abreu (Burlington, United States of America), T. H. Hampton (Hanover, United States of America), R. A Cramer (Hanover, United States of America), B. A. Stanton (Hanover, United States of America), M. Wargo (Burlington, United States of America), D. J Weiss (Burlington, United States of America)
| |
Lung extracellular matrix hydrogel for 3D bioprinting of lung mesenchymal stem cells
I. Almendros (Barcelona, Spain), J. Otero (Barcelona-Madrid, Spain), B. Falcones (Barcelona, Spain), E. Marhuenda (Barcelona, Spain), D. Navajas (Barcelona, Spain), R. Farre (Barcelona, Spain)
| |
Human mesenchymal stem cell exosomes attenuate inflammation of lung epithelial cells through miR-223 in acute lung injury
J. Chen (Changsha, China), P. Pan (Changsha, China), M. Li (Changsha, China), R. Lu (Changsha, China), Y. Fang (Changsha, China), C. Hu (Changsha, China)
| |
The therapeutic potential of the mesenchymal stem cell secretome in a mouse model of chronic inflammatory lung disease
L. Roets (Belfast, United Kingdom), D. Doherty (Belfast, United Kingdom), R. Delaney (Belfast, United Kingdom), A. Krasnodembskaya (Belfast, United Kingdom), M. Mall (Berlin, Germany), C. Taggart (Belfast, United Kingdom), S. Weldon (Belfast, United Kingdom)
| |
Collagen VI-producing macrophages mediate lung fibrosis
Á. Ucero (Madrid, Spain), L. Bakiri (Madrid, Spain), E. Wagner (Vienna, Austria)
| |
Role of alevoalr macrophages and CD4 in ALI/ARDS in mice
N. Alekhmimi (Riyadh, Saudi Arabia), P. Kvietys (Riyadh, Saudi Arabia)
| |
Effect of bronchial neutrophilia on airway remodeling in asthma
M. Bullone (Orbassano, Italy), V. Carriero (Orbassano, Italy), F. Bertolini (Orbassano, Italy), F. Ricciardolo (Orbassano, Italy)
| |
Sphingosine-1-phosphate receptor 1 controls endothelial cells permeability and function through the Bone morphogenetic 9/Endoglin signaling pathway.
B. Wang (Wenzhou, China), Y. Yu (Zhuji, China), D. Wu (Wenzhou, China), C. Song (Wenzhou, China), D. Qiu (Wenzhou, China), S. Bellusci (Wenzhou, China), J. Zhang (Wenzhou, China), K. Dai (Wenzhou, China), C. Chen (Wenzhou, China)
| |
Hedgehog pathway activation is altered in COPD patients
R. Belgacemi (Reims, France), J. Ancel (Reims, France), J. Perotin (Reims, France), E. Luczka (Reims, France), A. Germain (Reims, France), G. Delepine (Reims, France), X. Dubernard (Reims, France), J. Mérol (Reims, France), M. Polette (Reims, France), G. Deslée (Reims, France), V. Dormoy (Reims, France)
| |